Cervical Human Papillomavirus Testing: Current and Future Impact on Patient Care.


Journal

Surgical pathology clinics
ISSN: 1875-9157
Titre abrégé: Surg Pathol Clin
Pays: United States
ID NLM: 101491209

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: ppublish

Résumé

Cervical cancer is the fourth most common malignancy in women worldwide. The identification of human papillomavirus (HPV) as the main etiologic cause of cervical cancer has led to the development and adaptation of HPV molecular diagnostics as a cervical cancer screening and prevention tool. This article highlights six Food and Drug Administration-approved HPV molecular platforms, each with unique advantages and disadvantages. In addition, HPV vaccination and the emergence of HPV self-collection as an alternative testing strategy are discussed.

Identifiants

pubmed: 39129141
pii: S1875-9181(24)00017-5
doi: 10.1016/j.path.2024.04.006
pii:
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-439

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors declare no conflicts of interest.

Auteurs

Carol N Rizkalla (CN)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, 1959 NE Pacific Street, Box 357470, Seattle, WA 98195, USA. Electronic address: https://twitter.com/Carol2Path.

Eric C Huang (EC)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Harborview Medical Center, 325 9th Avenue, Box 359791, Seattle, WA 98104, USA. Electronic address: ecchuang@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH